When should premixed insulin 70/30 (70% intermediate‑acting insulin, 30% rapid‑acting insulin) be initiated according to the ADA 2025 guidelines in an 80‑kg adult patient on metformin and a sulfonylurea who has not achieved glycemic targets?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

When to Start Insulin 70/30 Based on ADA 2025 Guidelines

According to ADA 2025 guidelines, premixed insulin 70/30 should be considered when A1C remains above goal after initiating basal insulin, or as an alternative intensification strategy when transitioning from twice-daily NPH insulin in patients with type 2 diabetes who have not achieved glycemic targets on oral agents. 1

Clinical Context for Premixed Insulin Initiation

The ADA 2025 guidelines position premixed insulin 70/30 within a stepwise intensification algorithm rather than as a first-line injectable therapy. Here's the specific pathway:

Primary Injectable Therapy Sequence

  • First injectable consideration: Basal insulin (10 units/day or 0.1-0.2 units/kg/day) OR GLP-1 receptor agonist, depending on patient-specific factors including cardiovascular disease, weight, and cost 1
  • If basal insulin alone fails to achieve A1C goal: The guidelines recommend evaluating for "overbasalization" (high bedtime-to-morning glucose differential, hypoglycemia, high glucose variability) 1

When Premixed 70/30 Enters the Algorithm

Premixed insulin 70/30 becomes appropriate in two specific scenarios 1:

  1. Converting from twice-daily NPH: When patients on bedtime NPH need intensification, consider converting to a twice-daily NPH plan, which can then incorporate premixed insulin

    • Dosing: 2/3 of total daily dose given before breakfast, 1/3 before dinner
    • Add 4 units of short/rapid-acting insulin to each injection OR 10% of reduced NPH dose

  2. Alternative to basal-bolus: When stepwise prandial insulin addition is needed but a simpler regimen is preferred

    • This is explicitly mentioned as "twice-daily premixed insulin plan" in the intensification pathway

Practical Dosing for Your 80-kg Patient

For an 80-kg adult on metformin and sulfonylurea with inadequate control:

Initial Approach

  • Do NOT start with premixed 70/30 as first injectable 1
  • Start with basal insulin: 8-16 units/day (0.1-0.2 units/kg × 80 kg)
  • Titrate basal insulin using algorithm: increase 2 units every 3 days to reach fasting plasma glucose goal

If Basal Insulin Fails

  • Assess for overbasalization signs: If fasting glucose is controlled but A1C remains elevated, postprandial glucose is likely the issue 1
  • Then consider premixed 70/30:
    • Convert total daily basal dose to premixed regimen
    • Split as 2/3 morning, 1/3 evening
    • The 70% intermediate-acting component provides basal coverage
    • The 30% rapid-acting component addresses postprandial excursions

Critical Caveats

Continue metformin with insulin 1: The guidelines explicitly state that metformin combined with insulin reduces weight gain, lowers insulin dose requirements, and decreases hypoglycemia risk. Do not discontinue oral agents abruptly when starting insulin.

Sulfonylurea considerations: While the guidelines don't mandate discontinuation, consider reducing or stopping the sulfonylurea when initiating insulin to minimize hypoglycemia risk, particularly with premixed formulations that have both basal and prandial components.

Reassess every 3-6 months 1: The guidelines emphasize avoiding therapeutic inertia through regular reassessment and modification.

Why Not Start with Premixed 70/30?

The ADA 2025 guidelines clearly prioritize basal insulin or GLP-1 RA as first injectable therapy 1. Premixed insulins are positioned as intensification options because:

  • They provide less flexibility for dose adjustment
  • They carry higher hypoglycemia risk than basal insulin alone (research shows 3.4 vs 0.7 episodes/year) 2
  • They require more rigid meal timing
  • Basal insulin allows simpler titration to target fasting glucose first

The guideline algorithm shows premixed insulin as a "consider" option during intensification, not as initial injectable therapy 1.

References

Related Questions

For a 70‑kg adult, how many units of Actrapid (regular insulin) and premixed insulin (e.g., 70/30) should be given daily and how should the doses be divided among meals?
After administering 10 units of morning basal insulin, the fasting glucose is 70 mg/dL; what adjustment, if any, should be made to the insulin dose?
In a 50‑year‑old man with blood pressure 130/100 mmHg and a 75‑g oral glucose tolerance test showing fasting glucose 244 mg/dL and 2‑hour glucose 375 mg/dL, what are the appropriate management strategies and medication options if he refuses insulin?
For a 72‑year‑old woman with type 2 diabetes, weight 44 kg, serum creatinine 0.57 mg/dL (eGFR > 90 mL/min/1.73 m²), on prednisone 30 mg daily, currently using NPH insulin 15 U at 08:00 with an insulin‑sensitivity factor of 25 mg/dL per unit and an insulin‑to‑carbohydrate ratio of 10 g per unit, and with glucose readings of 127 mg/dL at 08:00, 364 mg/dL at 13:00 after 80 g carbohydrate, 314 mg/dL at 17:00 after 30 g carbohydrate, and 268 mg/dL at 21:00, what should the NPH insulin dose, insulin‑sensitivity factor, and insulin‑to‑carbohydrate ratio be?
How should I evaluate and manage a 52-year-old female with a 15-year history of type 2 diabetes on premixed insulin (30/70) who presents with generalized body aches, mild dizziness, tachycardia, hypertension, and a random blood glucose of 256 mg/dL?
Which central nervous system depressants can be used safely with metoprolol without causing drug interactions?
Which antidepressant agents can be co‑prescribed with metoprolol without clinically significant drug interactions?
What foods should be avoided in patients with fatty liver disease?
What are the recommended vegetarian sources of vitamin B12 and appropriate supplementation strategies?
Can a pregnant woman receive a tetanus toxoid (Td) injection after 13 weeks gestation?
In a 35-year-old patient with a platelet count of 154 ×10⁹/L, is this value normal and does it warrant further evaluation for liver disease (e.g., calculation of the FIB‑4 score)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.